Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease

Completed

Conditions studied: Squamous Cell Lung Cancer, Lung Cancer

In brief

This study will evaluate a new imaging technology, termed optical frequency domain imaging (OFDI) for detecting and diagnosing pulmonary malignancy in the central airways.

Key facts

Study ID

NCT01396603

Run by

Massachusetts General Hospital

People needed

30

Starts

2008-12-01

Expected to finish

2018-01-01

Last updated by the study team

2018-03-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing bronchoscopy for known or suspected pulmonary malignancy in the central airways
• Patients must be over the age of 18
• Patient must be able to give informed consent
• Women with child bearing potential must have a negative pregnancy test the day before or the day of the procedure.

You may not qualify if…

• Patient does not meet the requirements to undergo clinical bronchoscopy, as determined by the treating physician.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.